Clinical trial • Phase III • Oncology

Clinical trial in Small cell lung cancer|Small cell lung cancer, metastatic|Small cell lung cancer, limited stage

Phase III trial for Small cell lung cancer|Small cell lung cancer, metastatic|Small cell lung cancer, limited stage. 15 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Small cell lung cancer|Small cell lung cancer, metastatic|Small cell lung cancer, limited stage
Trial Stage
Phase III
Drug Modality
Radiopharmaceutical

Key dates

Initial CTIS Submission Date
31-01-2025
First CTIS Authorization Date
06-05-2025

Trial design

Phase III trial across 3 sites in France.

Target Sample Size
15

Recruitment

Planned Sample Size
15
Recruitment Window Months
43

Geography

Total Number Of Sites
3
Total Number Of Participants
15

France

Earliest CTIS Part Ii Submission Date
28-03-2025
Latest Decision Or Authorization Date
12-03-2026
Processing Time Days
349
Number Of Sites
3
Number Of Participants
15

Sites

Site Name
Institut De Cancerologie De L Ouest
Department Name
Nuclear Medicine
Principal Investigator Name
Marie LACOMBE
Principal Investigator Email
marie.lacombe@ico.unicancer.fr
Contact Person Name
Marie LACOMBE
Contact Person Email
marie.lacombe@ico.unicancer.fr
Site Name
Centre Hospitalier Regional D'Angers
Department Name
Nuclear Medicine
Principal Investigator Name
Clément BOURON
Principal Investigator Email
clbouron@chu-angers.fr
Contact Person Name
Clément BOURON
Contact Person Email
clbouron@chu-angers.fr
Site Name
Institut De Cancerologie De L Ouest
Department Name
Nuclear Medicine
Principal Investigator Name
Marie LACOMBE
Principal Investigator Email
marie.lacombe@ico.unicancer.fr
Contact Person Name
Marie LACOMBE
Contact Person Email
marie.lacombe@ico.unicancer.fr

Sponsor

Primary sponsor

Full Name
Institut De Cancerologie De L Ouest
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.